Infant Gut Health Market - 2023-2032

November 2025 | 210 pages | ID: I91DB553C928EN
DataM Intelligence

Abstracts

The Infant Gut Health Market was valued at US$ 8,321.01 million in 2023 and is anticipated to reach US$ 15,557.12 million by 2032, at a CAGR of 0.072 from 2026 to 2032.

The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Infant Gut Health Market.

This report delivers a comprehensive overview of the Infant Gut Health Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Infant Gut Health Market. The Infant Gut Health Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2023–2032.

Infant Gut Health Market Scope:

By Product Type

• Probiotics
• Prebiotics
• Postbiotics
• Others

By Form

• Liquid
• Powder
• Others

By Application

• Diarrhea Management
• Constipation Management
• Immune Support
• Others

By Distribution Channel

• Supermarkets & Hypermarkets
• Pharmacies / Drug Stores
• Online Retail
• Specialty Stores
• Others

Key Players

• Nestle S.A.
• Danone S.A
• Abbott Laboratories
• BioGaia AB
• Reeckitt Benckiser Group
• PROBI AB
• Chr. Hansen A/S
• dsm-firmenich
• Amyway

Major Highlights

This report delivers a comprehensive overview of the Infant Gut Health Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Infant Gut Health Market. The Infant Gut Health Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2023–2032.

This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Regional Analysis:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Partner Identification

• Increase Your Customer Base by 3X using our Partner Identification tool
• Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
• Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
• Prioritize partners by strategic fit rather than general capability.

Why Choose DataM?

• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2026

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Contents

1. METHODOLOGY AND SCOPE

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. DEFINITION AND OVERVIEW

3. EXECUTIVE SUMMARY

3.1. Snippet by Product Type
3.2. Snippet by Form
3.3. Snippet by Application
3.4. Snippet by Distribution Channel
3.5. Snippet by Region

4. DYNAMICS

4.1. Impacting Factors
  4.1.1. Drivers
    4.1.1.1. Growing Incidence of Digestive Disorders
    4.1.1.2. Expansion of Over-the-Counter (OTC) and Online Distribution Channels
  4.1.2. Restraints
    4.1.2.1. Inconsistent Regulation and Product Quality Concerns
  4.1.3. Opportunity
  4.1.4. Trends
  4.1.5. Impact Analysis

5. INDUSTRY ANALYSIS

5.1. Porter's Five Forces Analysis
5.2. Pricing Analysis
  5.2.1. Historical Price Trends
  5.2.2. Future Price Forecast
  5.2.3. Factors Influencing Pricing
  5.2.4. Competitive Pricing Strategies
5.3. Regulatory and Tariff Analysis
5.4. Go-to-market (GTM) Strategies
5.5. Sustainability & ESG Analysis
5.6. Technological Analysis
5.7. Value Chain Analysis
5.8. Consumer Behavior and Insights
5.9. DMI Opinion

6. BY PRODUCT TYPE

6.1. Introduction
  6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  6.1.2. Market Attractiveness Index, By Product Type
6.2. Probiotics*
  6.2.1. Introduction
  6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Prebiotics
6.4. Postbiotics
6.5. Others

7. BY FORM

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  7.1.2. Market Attractiveness Index, By Form
7.2. Liquid*
  7.2.1. Introduction
  7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Powder
7.4. Others

8. BY APPLICATION

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  8.1.2. Market Attractiveness Index, By Application
8.2. Diarrhea Management*
  8.2.1. Introduction
  8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Constipation Management
8.4. Immune Support
8.5. Others

9. BY DISTRIBUTION CHANNEL

9.1. Introduction
  9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  9.1.2. Market Attractiveness Index, By Distribution Channel
9.2. Supermarkets & Hypermarkets*
  9.2.1. Introduction
  9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Pharmacies / Drug Stores
9.4. Online Retail
9.5. Specialty Stores
9.6. Others

10. BY REGION

10.1. Introduction
  10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  10.1.2. Market Attractiveness Index, By Region
10.2. North America
  10.2.1. Introduction
  10.2.2. Key Region-Specific Dynamics
  10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    10.2.7.1. US
    10.2.7.2. Canada
    10.2.7.3. Mexico
10.3. Europe
  10.3.1. Introduction
  10.3.2. Key Region-Specific Dynamics
  10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    10.3.7.1. Germany
    10.3.7.2. UK
    10.3.7.3. France
    10.3.7.4. Italy
    10.3.7.5. Spain
    10.3.7.6. Poland
    10.3.7.7. Russia
    10.3.7.8. Belgium
    10.3.7.9. The Netherlands
    10.3.7.10. Luxembourg
    10.3.7.11. Denmark
    10.3.7.12. Rest of Europe
10.4. South America
  10.4.1. Introduction
  10.4.2. Key Region-Specific Dynamics
  10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    10.4.7.1. Brazil
    10.4.7.2. Argentina
    10.4.7.3. Chile
    10.4.7.4. Colombia
    10.4.7.5. Rest of South America
10.5. Asia-Pacific
  10.5.1. Introduction
  10.5.2. Key Region-Specific Dynamics
  10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    10.5.7.1. China
    10.5.7.2. Japan
    10.5.7.3. South Korea
    10.5.7.4. India
    10.5.7.5. Australia
    10.5.7.6. New Zealand
    10.5.7.7. SEA Countries
      10.5.7.7.1. Indonesia
      10.5.7.7.2. Malaysia
      10.5.7.7.3. Philippines
      10.5.7.7.4. Singapore
      10.5.7.7.5. Thailand
      10.5.7.7.6. Vietnam
      10.5.7.7.7. Rest of SEA Countries
    10.5.7.8. Rest of Asia-Pacific
10.6. Middle East and Africa
  10.6.1. Introduction
  10.6.2. Key Region-Specific Dynamics
  10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  10.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    10.6.7.1. GCC Countries
      10.6.7.1.1. Bahrain
      10.6.7.1.2. Kuwait
      10.6.7.1.3. Oman
      10.6.7.1.4. Qatar
      10.6.7.1.5. Saudi Arabia
      10.6.7.1.6. UAE
    10.6.7.2. Israel
    10.6.7.3. South Africa
    10.6.7.4. North Africa
    10.6.7.5. Rest of Middle East and Africa

11. COMPETITIVE LANDSCAPE ANALYSIS

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
11.4. Partner Identification Analysis
11.5. Investment & Funding Landscape
11.6. Strategic Alliances & Innovation Pipelines

12. COMPANY PROFILES

12.1. Nestl? S.A.*
  12.1.1. Company Overview
  12.1.2. Product Portfolio and Description
  12.1.3. Product Sales Footprint
  12.1.4. Company Financial Overview
  12.1.5. Key Developments
  12.1.6. SWOT Analysis
  12.1.7. Strategic Insights
12.2. Danone S.A
12.3. Abbott Laboratories
12.4. BioGaia AB
12.5. Reeckitt Benckiser Group
12.6. PROBI AB
12.7. Chr. Hansen A/S
12.8. dsm-firmenich
12.9. Amyway
12.10. Chr. Hansen A/S (LIST NOT EXHAUSTIVE)

13. APPENDIX

13.1. About Us and Services
13.2. Contact Us